Skip to main content
IVZ
NYSE Finance

Invesco Shareholders Approve Enhanced Governance, Allowing Director Removal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Asset Management Stocks · Financial
Sentiment info
Positive
Importance info
7
Price
$27.03
Mkt Cap
$11.991B
52W Low
$14.1
52W High
$29.61
52W Position info
92% above low
Off High info
8.7% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

IVZ sits 92% above its 52-week low of $14.1.

Summary

Invesco Ltd. shareholders approved an amendment to the company's bye-laws, enabling directors to be removed with or without cause, alongside other routine annual meeting proposals. This enhances shareholder oversight and board accountability.


Key Events · Corporate Governance and Compliance · IVZ

  • Shareholder-Friendly Governance Approved

    Shareholders approved an amendment to the company's Fourth Amended and Restated Bye-Laws, allowing directors to be removed with or without cause. This was a significant governance change proposed in earlier proxy filings.

  • Board of Directors Elected

    All eleven nominated directors were elected to the board during the Annual General Meeting.

  • Executive Compensation Approved

    Shareholders approved, on an advisory and non-binding basis, the compensation paid to named executive officers.

  • Auditor Reappointed

    PricewaterhouseCoopers LLP was reappointed as the independent registered public accounting firm for the fiscal year ending December 31, 2026.


Analysis · IVZ · Finance

The approval of the bye-laws amendment to allow shareholders to remove directors with or without cause is a significant enhancement of corporate governance. This change increases board accountability and shareholder power, which is generally viewed favorably by investors and governance advocates. While the proposal was previously disclosed, its formal approval marks a concrete step towards stronger shareholder rights.

At the time of this filing, IVZ was trading at $27.03 on NYSE in the Finance sector, with a market capitalization of approximately $12B. The 52-week trading range was $14.10 to $29.61. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IVZ - Latest Insights

IVZ
Jul 10, 2026, 8:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.67
Real-time Price: $29.15 info
Change: +$0.480 (+2%) info
Market Cap: $12.922B info
IVZ
Jun 10, 2026, 8:45 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $27.40
Real-time Price: $29.15 info
Change: +$1.75 (+6%) info
Market Cap: $12.922B info
IVZ
Jun 09, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $27.89
Real-time Price: $29.15 info
Change: +$1.26 (+5%) info
Market Cap: $12.922B info
IVZ
Jun 01, 2026, 7:49 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.36
Real-time Price: $29.15 info
Change: +$0.790 (+3%) info
Market Cap: $12.922B info
IVZ
May 22, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $27.03
Real-time Price: $29.15 info
Change: +$2.12 (+8%) info
Market Cap: $12.922B info
IVZ
May 11, 2026, 4:22 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $27.99
Real-time Price: $29.15 info
Change: +$1.16 (+4%) info
Market Cap: $12.922B info
IVZ
May 05, 2026, 2:09 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $26.77
Real-time Price: $29.15 info
Change: +$2.38 (+9%) info
Market Cap: $12.922B info
IVZ
Apr 28, 2026, 7:21 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $25.13
Real-time Price: $29.15 info
Change: +$4.02 (+16%) info
Market Cap: $12.922B info
IVZ
Apr 28, 2026, 6:56 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.48
Real-time Price: $29.15 info
Change: +$3.67 (+14%) info
Market Cap: $12.922B info
IVZ
Apr 02, 2026, 4:02 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $24.14
Real-time Price: $29.15 info
Change: +$5.01 (+21%) info
Market Cap: $12.922B info